Inicio › Cáncer de pulmón de células no pequeñas › Florida › Sarasota
Ensayos clínicos de Cáncer de pulmón de células no pequeñas en Sarasota, FL
17 estudios para Cáncer de pulmón de células no pequeñas buscan participantes en centros de Sarasota y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Florida Cancer Specialists, Sarasota
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
ReclutandoFase 1
- Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ReclutandoFase 3
- Florida Cancer Specialists, Sarasota
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- Florida Cancer Specialists, Sarasota
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
ReclutandoFase 1/2
- Florida Cancer Specialists & Research Institute - Sarasota, Sarasota
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
ReclutandoFase 2/3
- Local Institution - 007-922-I, Sarasota
- Local Institution - 007-922-J, Sarasota
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
ReclutandoFase 1/2
- Florida Cancer Specialists, Sarasota
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Florida Cancer Specalists, Sarasota
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
ReclutandoFase 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
ReclutandoFase 1
- Florida Cancer Specialists, Sarasota
A Study of LY4175408 in Participants With Advanced Cancer
ReclutandoFase 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
ReclutandoFase 1
- Florida Cancer Specialists, Sarasota
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
ReclutandoFase 1
- Florida Cancer Specialists, Sarasota
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
ReclutandoFase 1
- Florida Cancer Specialists, Sarasota
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
ReclutandoFase 1/2
- Florida Cancer Specialists, Sarasota
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- Florida Cancer Specialists, Sarasota
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
ReclutandoFase 1
- Dren Investigational Site, Sarasota
Ensayos de Cáncer de pulmón de células no pequeñas en otras ciudades
- Houston, TX145 estudios
- New York City, NY121 estudios
- Arlington, VA104 estudios
- Nashville, TN97 estudios
- Boston, MA90 estudios
- Los Angeles, CA87 estudios
- St. Louis, MO73 estudios
- Chicago, IL61 estudios
- Baltimore, MD60 estudios
- San Antonio, TX59 estudios
- Columbus, OH57 estudios
- Washington, DC55 estudios
Otros estudios en Sarasota
- Cáncer metastásico19 estudios
- Cáncer del colon y del recto16 estudios
- Cáncer de ovario16 estudios
- Cáncer de endometrio14 estudios
- Cáncer de seno12 estudios
- Cáncer (todos los tipos)11 estudios
- Cáncer de mama triple negativo8 estudios
- Cáncer de pulmón7 estudios
- Cáncer de páncreas7 estudios
- Fibrilación auricular7 estudios
- Cáncer de próstata6 estudios
- Esteatosis hepática6 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.